Q

Robust Sales Growth Make Iqvia Holdings (Q) a Buy

Currently, Iqvia Holdings Inc (NYSE:Q) has a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking Q has had from Portfolio Grader for the last month.

Quintiles IMS Holdings’ (Q) Healthy Earnings Visibility Keep it a Buy

As one of the 785 companies in the GICS Health Care sector Quintiles IMS Holdings Inc (NYSE:Q) is a constituent of the 33 company Life Sciences Tools & Services GICS industry group within this sector. Q has a market value of $25.5 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for Q puts it 14 among the 33 companies in this industry group, giving it an above-average position; in the top quartile of the sector with a ranking of 183 among the 785 companies in the sector, and number 1,180 in the nearly 5,000 company Portfolio Grader universe.

Quintiles IMS Holdings (Q) a Buy on Solid Sales Growth

Quintiles IMS Holdings Inc (NYSE:Q) is classified as a constituent of the 33 company Life Sciences Tools & Services GICS industry group, which is part of the 783 company GICS Health Care sector. The market value of Q is $25.4 billion which falls in the top decile in its industry group. The ranking for Q by Portfolio Grader places it 11 among the 33 companies in this industry group, giving it an above-average position; in the top quartile of the sector with a ranking of 106 among the 783 companies in the sector, and number 729 in the nearly 5,000 company Portfolio Grader universe.

Quintiles IMS Holdings (Q) a Buy on Strong Earnings Momentum

Quintiles IMS Holdings Inc (NYSE:Q) ranks in the top decile in its industry group, Life Sciences Tools & Services, and in the top decile of sector group, Health Care, with a market value of $22.3 billion. From an investment attractiveness viewpoint, Q is ranked in the top quartile of the sector with a ranking of 163 among the 782 companies in the sector; the ranking for Q by Portfolio Grader places it 13 among the 33 companies in this industry group, placing it in the top half and number 1,176 in the 5000 company Portfolio Grader company universe.

Quintiles IMS Holdings’ (Q) Upgraded to Buy

With a $21.6 billion market value, Quintiles IMS Holdings Inc (NYSE:Q) ranks in the top 10% of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for Q by Portfolio Grader places it 16 among the 33 companies in this industry group, giving it an above-average position; in the top half of the sector with a ranking of 221 among the 783 companies in the sector, and number 1,599 in the nearly 5,000 company Portfolio Grader universe.

Quintiles IMS Holdings’ (Q) Shares Have Buy Rating Remain in Place

The current recommendation of Buy for Quintiles IMS Holdings Inc (NYSE:Q) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. Q has maintained this ranking for the last month.

Quintiles IMS Holdings’ (Q) Shares Have Buy Rating Remain in Place

The current recommendation of Buy for Quintiles IMS Holdings Inc (NYSE:Q) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. Q has maintained this ranking for the last month.

Baxter International Inc (BAX) and Asure Software Inc (ASUR) Lead 13 Activist Investor Filings

13D and 13G filings are a window into activist investor activity. We look at Baxter International and 12 other filings of note

4 Life Sciences Tools & Services Stocks to Sell Now

This week, the ratings of 4 Life Sciences Tools & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

11 Life Sciences Tools & Services Stocks to Sell Now

The overall ratings of 11 Life Sciences Tools & Services stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Life Sciences Tools & Services Stocks to Buy Now

7 Life Sciences Tools & Services stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

4 Life Sciences Tools & Services Stocks to Buy Now

The grades of 4 Life Sciences Tools & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Trade of the Day: Quintiles Transnational Holdings (Q)

Volatility, while pleasant on the upside, is not a sign of a stable market environment. Sharp reversals in stocks can happen at any time.

3 Life Science Stocks to Buy Now

The grades of three life science stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

3 Life Science Stocks to Buy Now

This week, three life science stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

3 Life Science Stocks to Buy Now

The grades of three life science stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").